purine nucleoside phosphorylase deficiency rare autosomal metabolic disorder results immunodeficiency addition symptoms associated immunodeficiency depletion tcells decline lymphocyte activity abrupt proliferation benign opportunistic often characterized development autoimmune disorders lupus erythematosus autoimmune hemolytic anemia idiopathic thrombocytopenic purpura reported neurological symptoms developmental decline hypotonia mental retardation also reportedcitation needed disorder caused mutation purine nucleoside phosphorylase pnp gene located chromosome mutation first identified eloise giblett professor university washington pnp key enzyme purine pathway required purine degradation specifically catalyzes conversion inosine hypoxanthine guanosine guanine guanine hypoxanthine made xanthine become uric acid deficiency leads buildup elevated deoxygtp dgtp levels resulting tcell toxicity contrast adenosine deaminase deficiency another deficiency purine metabolism minimal disruption b pnp deficiency inherited autosomal recessive means defective gene responsible disorder located autosome chromosome autosome two copies defective gene one inherited parent required order born disorder parents individual autosomal recessive disorder carry one copy defective gene usually experience signs symptoms disordercitation needed diagnosis based clinical examination laboratory findings showing leukopenia severe lymphopenia low counts variable b cell function immunoglobulin levels neutropenia also reported hallmark diagnostic markers pnp deficiency include hypouricemia complete near complete absence pnp activity red blood cell lysate increased urine blood levels inosine guanosine deoxy forms diagnosis confirmed genetic screening pnpcitation needed differential diagnosis includes aplastic anemias scid severe combined immunodeficiency due adenosine deaminase deficiency ataxiatelangiectasia viral meningoencephalitiscitation needed measurement cell receptor excision circles newborn screening scid detect patients pnp deficiency although removal metabolites maternal pnp may delay deleterious effects pnpdeficient lymphocytes newborn screening programs also measure purine metabolites driedcitation needed supportive treatment including intravenous immunoglobulin therapy prophylaxis pneumocystis carinii physical occupational speech therapy reduces risk infection may encourage optimal neurologic development patientscitation needed pnp deficiency extremely rare patients disorder united states united kingdom two children diagnosed disorder peripheral purine nucleoside phosphorylase deficiency httpsenwikipediaorgwikipurinenucleosidephosphorylasedeficiency